47D11
Covid-19 treatmentsNew and investigational drugs
4X-SA-GP
New and investigational drugsVaccines and vaccination
Antibiotic resistance and the development of new drugs
Antibiotic resistance (ABR)Antimicrobial resistance and the development of new antimicrobialsNew and investigational drugs
AstraZeneca coronavirus vaccine
Adenovirus vector vaccinesAstraZenecaCovid-19 vaccinesNew and investigational drugsUniversity of Oxford
Baloxavir
Influenza drugsNew and investigational drugs
COVAX-19
CovaxCovid-19 vaccinesNew and investigational drugsVaxine
CT-P59
CelltrionCovid-19 treatmentsNew and investigational drugs
DS-2969b
New and investigational drugs
Favipiravir
Influenza drugsNew and investigational drugs
GKT137831
New and investigational drugs
Johnson & Johnson COVID-19 vaccine
Adenovirus vector vaccinesCovid-19 vaccinesJohnson & JohnsonNew and investigational drugs
KapaVax
New and investigational drugs
LY-CoV555
Covid-19 antibody treatmentsEli LillyNew and investigational drugs
Moderna COVID‑19 vaccine
Covid-19 vaccinesModernaNew and investigational drugsRNA vaccines
N-hydroxycytidine (NHC)
Influenza drugsNew and investigational drugs
New and investigational antibiotics
New and investigational drugsSpecific antibiotics
New and investigational fungicides
New and investigational drugsSpecific fungicides
Novavax vaccine
Covid-19 vaccinesNew and investigational drugsNovavax
RBX2660
Fecal microbiota transplantation (FMT)New and investigational drugs
Regeneron (Covid-19 treatment)
Covid-19 antibody treatmentsNew and investigational drugsRegeneron
Ribaxamase
Beta-lactamasesNew and investigational drugs
Sanofi-GSK SARS-CoV-2 vaccine
Covid-19 vaccinesGlaxoSmithKline (GSK)New and investigational drugsSanofi

Showing topic

New and investigational drugs
Medications